Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa.

[1]  Rodney J. Knight,et al.  Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. , 2014, Journal of hepatology.

[2]  O. Laeyendecker,et al.  High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Ouédraogo,et al.  Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  S. Fiorillo,et al.  Seroprevalence of Hepatitis B and C Viruses Among Children in Kilimanjaro Region, Tanzania. , 2013, Journal of the Pediatric Infectious Diseases Society.

[5]  R. Tedder,et al.  The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa , 2013, Vaccine.

[6]  O. Pybus,et al.  Hepatitis C virus infections in the Democratic Republic of Congo exhibit a cohort effect. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  T. F. Rinke de Wit,et al.  HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes , 2013, Journal of acquired immune deficiency syndromes.

[8]  J. R. Nansseu,et al.  Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. , 2013, International Journal of Infectious Diseases.

[9]  F. Zoulim,et al.  High incidence of treatment‐induced and vaccine‐escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B–infected patients , 2013, Hepatology.

[10]  D. Pillay,et al.  Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis , 2013, PloS one.

[11]  G. Schutze,et al.  Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland , 2013, International journal of STD & AIDS.

[12]  D. Olive,et al.  Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing , 2013, PloS one.

[13]  Ayodotun Olutola,et al.  Prevalence and Clinical and Immunoviralogical Profile of Human Immunodeficiency Virus-Hepatitis B Coinfection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria , 2013, ISRN pediatrics.

[14]  W. Fawzi,et al.  Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania , 2013, AIDS.

[15]  P. Bessong,et al.  Hepatitis B virus in HIV-infected patients in northeastern South Africa: prevalence, exposure, protection and response to HAART. , 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[16]  K. Mandaliya,et al.  Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy , 2013, PloS one.

[17]  A. Mihret,et al.  Hepatitis C virus and Human Immunodeficiency Virus coinfection among attendants of Voluntary Counseling and Testing Centre and HIV follow up clinics in Mekelle Hospital , 2013, The Pan African medical journal.

[18]  Sheena McCormack,et al.  Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. , 2013, World journal of gastroenterology.

[19]  E. Nwolisa,et al.  Prevalence of Hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-eastern Nigeria , 2013, The Pan African medical journal.

[20]  Seema Meloni,et al.  Impact of Hepatitis C Virus on HIV Response to Antiretroviral Therapy in Nigeria , 2013, Journal of acquired immune deficiency syndromes.

[21]  F. Pereira,et al.  Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. , 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[22]  S. Kulkarni,et al.  Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort , 2013, AIDS.

[23]  R. Phillips,et al.  Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa , 2013, AIDS.

[24]  E. Boyko,et al.  The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection , 2013, Hepatology.

[25]  A. Tremeau-Bravard,et al.  Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. , 2013, African health sciences.

[26]  E. Mills,et al.  Cohort profile: the MUg Observational Cohort. , 2012, International journal of epidemiology.

[27]  Z. Fox,et al.  Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana. , 2012, The Journal of antimicrobial chemotherapy.

[28]  N. Martinson,et al.  Hepatitis B Virus Infection in Human Immunodeficiency Virus Infected Southern African Adults: Occult or Overt – That Is the Question , 2012, PLoS ONE.

[29]  G. Gray,et al.  Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa , 2012, International journal of STD & AIDS.

[30]  R. Burnett,et al.  An update after 16 years of hepatitis B vaccination in South Africa. , 2012, Vaccine.

[31]  T. M. Balogun,et al.  HIV, Hepatitis B and C viruses’ coinfection among patients in a Nigerian tertiary hospital , 2012, The Pan African medical journal.

[32]  S. Eholie,et al.  Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. , 2012, World journal of hepatology.

[33]  S. Lewin,et al.  HIV replication is associated with increased severity of liver biopsy changes in HIV‐HBV and HIV‐HCV co‐infection , 2012, Journal of medical virology.

[34]  D. Jamieson,et al.  HIV-HBV coinfection--a global challenge. , 2012, The New England journal of medicine.

[35]  M. Sulkowski,et al.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. , 2012, Gastroenterology.

[36]  M. Maskew,et al.  Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[37]  A. Mamman,et al.  Molecular Epidemiology of Hepatitis C Virus (HCV) in Kadun State , 2012 .

[38]  Desmond J. Martin,et al.  HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS. , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[39]  Pei-Jer Chen,et al.  Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  E. Delaporte,et al.  Lamivudine-Resistant HBV Infection in HIV-Positive Patients Receiving Antiretroviral Therapy in a Public Routine Clinic in Cameroon , 2012, Antiviral therapy.

[41]  K. Sagoe,et al.  Prevalence and impact of hepatitis B and C virus co‐infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana , 2012, Journal of medical virology.

[42]  S. Rowland-Jones,et al.  Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa , 2011, BMC Research Notes.

[43]  C. Gnoula,et al.  HCV prevalence and co‐infection with HIV among pregnant women in Saint Camille Medical Centre, Ouagadougou , 2011, Tropical medicine & international health : TM & IH.

[44]  K. Sherman,et al.  HIV/hepatitis C coinfection natural history and disease progression. , 2011, Current opinion in HIV and AIDS.

[45]  C. Leen,et al.  Hepatitis delta in HIV-infected individuals in Europe , 2011, AIDS.

[46]  Zonghui Hu,et al.  Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa , 2011, AIDS.

[47]  G. Anabwani,et al.  Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana. , 2011, The American journal of tropical medicine and hygiene.

[48]  R. Colebunders,et al.  Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda. , 2011, African health sciences.

[49]  Ming‐Lung Yu,et al.  Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups , 2011, The Kaohsiung journal of medical sciences.

[50]  B. Chi,et al.  HIV, Hepatitis B, and Hepatitis C in Zambia , 2011, Journal of global infectious diseases.

[51]  B. McMahon,et al.  Treatment of chronic hepatitis B virus infection in resource‐constrained settings: expert panel consensus , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[52]  L. Gravitz.  Introduction: A smouldering public-health crisis , 2011, Nature.

[53]  A. Wensing,et al.  Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa , 2011, Journal of medical virology.

[54]  Ajayi Iyiade Adeseye,et al.  Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria , 2011, The Pan African medical journal.

[55]  C. Toro,et al.  Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[56]  Cheng-bo Yu,et al.  Prevalence of hepatitis B and C in HIV-infected patients: a meta-analysis. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[57]  O. Laeyendecker,et al.  High Prevalence of Liver Fibrosis Associated with HIV Infection: A Study in Rural Rakai, Uganda , 2011, Antiviral therapy.

[58]  Katyna Borroto-Esoda,et al.  No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus , 2011, Hepatology.

[59]  N. Dominique,et al.  High prevalence and predominance of Hepatitis D genotype 1 infection in Cameroon , 2011 .

[60]  R. Njouom,et al.  High Prevalence and Predominance of Hepatitis Delta Virus Genotype 1 Infection in Cameroon , 2011, Journal of Clinical Microbiology.

[61]  A. Sagoe,et al.  Seroepidemiology of hepatitis-B surface antigenaemia in HIV positive patients. , 2011, West African journal of medicine.

[62]  C. Okafor,et al.  Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting , 2011, Virology Journal.

[63]  R. Barth,et al.  Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[64]  G. Odaibo,et al.  Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan. , 2010, African journal of medicine and medical sciences.

[65]  S. Eholie,et al.  Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire , 2010, Antiviral therapy.

[66]  S. Rowland-Jones,et al.  Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians , 2010, Virology Journal.

[67]  N. Beeching,et al.  Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection. , 2010, The Journal of infection.

[68]  M. Leal,et al.  Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine. , 2010, The Journal of infectious diseases.

[69]  F. Sarfo,et al.  Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in Ghana , 2010, Journal of Clinical Microbiology.

[70]  S. Nordbø,et al.  Streptococcus agalactiae colonization and correlation with HIV-1 and HBV seroprevalence in pregnant women from Zimbabwe. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[71]  C. Gnoula,et al.  Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[72]  P. Marcellin,et al.  The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[73]  E. Delaporte,et al.  Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon , 2010, BMC public health.

[74]  M. Kew.  Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. , 2010, World journal of hepatology.

[75]  C. I. Mboto,et al.  Hepatitis C virus prevalence and serotypes associated with HIV in The Gambia , 2010, British journal of biomedical science.

[76]  E. Delaporte,et al.  High rates of active hepatitis B and C co‐infections in HIV‐1 infected Cameroonian adults initiating antiretroviral therapy , 2010, HIV medicine.

[77]  C. Leen,et al.  British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010 , 2010, HIV medicine.

[78]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[79]  C. Akolo,et al.  A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria. , 2010, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.

[80]  M. Lemoine,et al.  HIV/hepatitis B virus co-infection: current challenges and new strategies. , 2010, The Journal of antimicrobial chemotherapy.

[81]  M. Maskew,et al.  HIV-HBV coinfection among South African patients receiving antiretroviral therapy. , 2010, Antiviral therapy.

[82]  H. Abubakar,et al.  Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. , 2010, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.

[83]  C. Rouzioux,et al.  Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children. , 2009, Journal of tropical pediatrics.

[84]  G. Degu,et al.  Seroprevalence of HIV, hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia , 2009 .

[85]  C. Thio,et al.  Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[86]  J. Lankoandé,et al.  [Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso]. , 2009, Bulletin de la Societe de pathologie exotique.

[87]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[88]  M. Magoni,et al.  Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district , 2009, Annals of tropical medicine and parasitology.

[89]  J. Forbi,et al.  Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. , 2009, Journal of infection in developing countries.

[90]  I. Sanne,et al.  Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[91]  A. Hatzakis,et al.  Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[92]  Rosamund F. Lewis,et al.  Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. , 2009, African health sciences.

[93]  M. Newell,et al.  HIV and HCV progression in parenterally coinfected children. , 2009, Current HIV research.

[94]  John T Brooks,et al.  Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[95]  R. Burnett,et al.  Increased detection of HBV DNA in HBsAg‐positive and HBsAg‐negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital , 2009, Journal of medical virology.

[96]  V. Soriano,et al.  Hepatitis B in HIV patients: what is the current treatment and what are the challenges? , 2009, Journal of HIV therapy.

[97]  S. Dao,et al.  Seroprevalence of HIV/HBV Coinfection in Malian Blood Donors , 2009, Journal of the International Association of Physicians in AIDS Care.

[98]  C. Leen,et al.  British HIV Association guidelines for the management of coinfection with HIV-1 and chronic hepatitis B or C 2009 , 2009 .

[99]  G. Leroux-Roels,et al.  Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic. , 2009, Vaccine.

[100]  M. Bakari,et al.  Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania , 2008, BMC public health.

[101]  R. Chaisson,et al.  Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  E. Delaporte,et al.  Hepatitis B, C seroprevalence and delta viruses in HIV‐1 Senegalese patients at HAART initiation (retrospective study) , 2008, Journal of medical virology.

[103]  A. De Luca,et al.  Serological response to hepatitis B virus vaccine in HIV‐infected children in Tanzania , 2008, HIV medicine.

[104]  V. Soriano,et al.  Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. , 2008, AIDS.

[105]  N. Beeching,et al.  Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. , 2008, The Journal of infection.

[106]  M. Nelson,et al.  HIV, hepatitis B and hepatitis C coinfection in Kenya , 2008, AIDS.

[107]  M. Mphahlele.  Impact of HIV co-infection on hepatitis B prevention and control: a view from sub-Saharan Africa , 2008 .

[108]  D. Dieterich,et al.  Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study. , 2008, Journal of hepatology.

[109]  Shou-Dong Lee,et al.  Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment , 2008, Journal of gastroenterology and hepatology.

[110]  V. Soriano,et al.  Hepatitis B virus escape mutants induced by antiviral therapy. , 2008, The Journal of antimicrobial chemotherapy.

[111]  I. Adewole,et al.  Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. , 2008, Annals of hepatology.

[112]  T. Powles,et al.  Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. , 2008, World journal of gastroenterology.

[113]  E. Katabira,et al.  The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. , 2008, African health sciences.

[114]  C. Rouzioux,et al.  Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[115]  P. Ingrand,et al.  Use of replacement blood donors to study the epidemiology of major blood‐borne viruses in the general population of Maputo, Mozambique , 2007, Journal of medical virology.

[116]  M. Giuliano,et al.  Seroprevalence of hepatitis B and C viruses among HIV‐infected pregnant women in Uganda and Rwanda , 2007, Journal of medical virology.

[117]  M. Matee,et al.  Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania , 2007, BMC public health.

[118]  R. Burnett,et al.  Mutations associated with lamivudine‐resistance in therapy‐naïve hepatitis B virus (HBV) infected patients with and without HIV co‐infection: Implications for antiretroviral therapy in HBV and HIV co‐infected South African patients , 2007, Journal of medical virology.

[119]  P. Klenerman,et al.  HCV–HIV Coinfection: Simple Messages from a Complex Disease , 2007, PLoS medicine.

[120]  G. Medhin,et al.  Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul’s General Specialised Hospital, Addis Ababa, Ethiopia , 2007, Sexually Transmitted Infections.

[121]  A. Savadogo,et al.  Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the Mother-to-Child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso. , 2007, Pakistan journal of biological sciences : PJBS.

[122]  D. Egah,et al.  Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. , 2007, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[123]  C. Thio,et al.  Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. , 2007, The Lancet. Infectious diseases.

[124]  J. Forbi,et al.  The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. , 2007, Memorias do Instituto Oswaldo Cruz.

[125]  Amita Gupta,et al.  Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[126]  V. Soriano,et al.  Hepatitis B Virus Genotypes and Lamivudine Resistance Mutations in HIV/Hepatitis B Virus-Coinfected Patients , 2007, Journal of acquired immune deficiency syndromes.

[127]  Tulio de Oliveira,et al.  Molecular Epidemiology: HIV-1 and HCV sequences from Libyan outbreak , 2006, Nature.

[128]  J. Kaldor,et al.  Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. , 2006, Journal of hepatology.

[129]  M. Bakari,et al.  Coinfection with HIV and HCV in a blood bank population in Dar es Salaam, Tanzania. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[130]  H. Becher,et al.  Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis , 2006, Journal of medical virology.

[131]  S. Lewin,et al.  Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy , 2006, AIDS.

[132]  J. Hou,et al.  Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection , 2006, International journal of medical sciences.

[133]  R. Burnett,et al.  High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[134]  R. Bruno,et al.  Natural history of chronic hepatitis B in co-infected patients. , 2006, Journal of hepatology.

[135]  M. Alter,et al.  Epidemiology of viral hepatitis and HIV co-infection. , 2006, Journal of hepatology.

[136]  A. Ronald,et al.  The Liver in HIV in Africa , 2005, Antiviral therapy.

[137]  A. Sadraoui,et al.  Infections par des virus transmissibles par le sang chez des hémophiles en Tunisie , 2005 .

[138]  C. Pasquier,et al.  Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. , 2005, The American journal of tropical medicine and hygiene.

[139]  Yoshiyuki Suzuki,et al.  Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan , 2005, Journal of medical virology.

[140]  L. Okoror,et al.  Human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenemia (HBSAG) among blood donors in Benin city, Edo state, Nigeria. , 2005, African health sciences.

[141]  C. Uneke,et al.  Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. , 2005, Memorias do Instituto Oswaldo Cruz.

[142]  E. Daar,et al.  Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. , 2005, The Journal of infectious diseases.

[143]  F. Carrat,et al.  Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. , 2004, JAMA.

[144]  B. Graham,et al.  Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[145]  S. Saab,et al.  Risk factors of accelerated liver fibrosis in HIV-HCV coinfection: a matched analysis: original , 2004 .

[146]  A. Wohl,et al.  Survival in patients with HIV infection and viral hepatitis B or C: a cohort study , 2004, AIDS.

[147]  Amy V. Groom,et al.  Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B , 2004, Hepatology.

[148]  F. Dabis,et al.  HBV and HCV prevalence and viraemia in HIV‐positive and HIV‐negative pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236 study , 2004, Journal of medical virology.

[149]  J. Montaner,et al.  Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. , 2004, The New England journal of medicine.

[150]  P. Volberding,et al.  Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. , 2004, The New England journal of medicine.

[151]  D. Pillay,et al.  HIV and hepatitis C coinfection within the CAESAR study , 2004, HIV medicine.

[152]  L. Perrin,et al.  Parallel and overlapping HIV and bloodborne hepatitis epidemics in Africa , 2004, International journal of STD & AIDS.

[153]  S. Darby,et al.  The impact of HIV on mortality rates in the complete UK haemophilia population , 2004, AIDS.

[154]  L. Seeff,et al.  Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. , 2003, Clinical chemistry.

[155]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[156]  M. Manns,et al.  Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. , 2002, Gastroenterology.